Compare Stocks

magicJack VocalTec Ltd., together with its subsidiaries, operates as a cloud communications company in the United States. The company's products and services allow users to make and/or receive free telephone calls to and from where the customer has broadband access to the Internet. It provides magicJack devices, such as The magicJack, magicJack PLUS, New magicJack PLUS, magicJack GO, and magicJack EXPRESS, which are voice-over-Internet-Protocol (VoIP) devices that enables customers to receive free VoIP phone service for their home, enterprise, or while traveling. The company also offers magicJack APP, an application that allows users to make and receive telephone calls through their smart phones using their magicJack account, as well as access to servers for a fee on a monthly or annual basis; and magicJack Connect App that offers Wi-Fi app-to-app calling and messaging services, as well as unlimited calling plans for the United States subscribers. In addition, it provides other magicJack-related products; and wholesales telephone services to VoIP providers and telecommunication carriers. Further, the company offers hosted unified communication as a service, as well as sells related hardware and network equipment to blue chip corporate customers; and VoIP services to small to medium sized businesses. It distributes its products through retail outlets, as well as direct sales. magicJack VocalTec Ltd. was founded in 1989 and is headquartered in Netanya, Israel.

Duff & Phelps Select Energy MLP Fund Inc. is a closed-ended equity mutual fund launched by Virtus Investment Partners, Inc. The fund is co-managed by Duff & Phelps Investment Management Co. and Virtus Alternative Investment Advisers, Inc. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the energy sector, with an emphasis on companies involved in the business of exploring, developing, producing, gathering, transporting, processing, storing, refining, distributing, mining, or marketing natural gas, natural gas liquids (including propane), crude oil, refined petroleum products or coal. It primarily invests in equity securities of midstream MLPs and stocks of companies across all market capitalizations. The fund employs both fundamental and quantitative analysis with a bottom-up stock picking approach, focusing on such factors as management philosophy and track record, competitive advantages via barriers to entry, long-term customer relationships and geographic footprint, regulatory landscape via permitting and export laws, quality of asset drop-down inventory including right of first offer, and assessment of fee-based contract structure including minimum volume commitments, inflation escalators, and take-or-pay provisions to create its portfolio. Duff & Phelps Select Energy MLP Fund Inc. was formed on March 28, 2014 and is domiciled in the United States.

Eskay Mining Corp., a natural resource company, engages in the acquisition and exploration of mineral properties, and precious and base metal deposits in British Columbia, Canada. It holds 100% interests in the ESKAY-Corey property located in northwestern British Columbia. The company was formerly known as Kenrich-Eskay Mining Corp. and changed its name to Eskay Mining Corp. in November 2009. The company was founded in 1980 and is headquartered in Toronto, Canada.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.